Dr. Chow Chung Hang James - Clinical Oncology
Specialist in Clinical Oncology
Highlights
- MCHK RegisteredVerified
- Specialist in Clinical OncologyBachelor of Medicine and Bachelor of Surgery (MBChB) · Hong Kong College of Radiologists · Medical degree 2011
- InsuranceBeing compiled｜See details
About
Dr. Chow Chung Hang James is a registered Clinical Oncology specialist in Hong Kong.
Education
Specialist in Clinical Oncology
- Bachelor of Medicine and Bachelor of Surgery (MBChB)Bachelor of Medicine and Bachelor of Surgery (MBChB)2011
Hong Kong Academy of Medicine fellowships
- FHKCRFellow, Hong Kong College of Radiologists
Source: Hong Kong Academy of Medicine Fellows Register, checked 12 Sep 2026
Insurance
Insurance plans being compiled
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Chow Chung Hang James? Claim page and update insurance →
FAQ
Is Dr. Chow Chung Hang James any good?
Dr. Chow Chung Hang James is a registered Clinical Oncology specialist in Hong Kong. Qualifications and registration come from the Hong Kong Medical Council. ok.med does not rate or rank doctors.
What does Dr. Chow Chung Hang James do?
Dr. Chow Chung Hang James practises in Clinical Oncology.
Are you Dr. Chow Chung Hang James? Claim this page to update and manage.
ClaimResearch and publications
21 papers · 12 most recent shown
Filter by paper topic
Topics come from medical classifications on these PubMed papers, not from the doctor's listed services.
- Cross-Platform Gene Signature to Predict Survival Outcomes for Nasopharyngeal Carcinoma.JCO precision oncology · 2026
- Management of Pulmonary Large-Cell Neuroendocrine Carcinoma (LCNEC): An Updated Review.Clinical lung cancer · 2026
- Predicting disease progression from the rate of bodyweight change in nasopharyngeal carcinoma patient during radiotherapy.Scientific reports · 2025
- Weight censorial score: estimation of the weight loss during concurrent chemo-radiotherapy in nasopharyngeal carcinoma patients by image features predicts prognosis.La Radiologia medica · 2025
- Interstitial Brachytherapy for Early Oral Cavity Squamous Cell Carcinoma: Long-Term Treatment Outcomes From a Single Tertiary Oncology Center.Cureus · 2025
- Optimal radiotherapy dose and fractionation for stereotactic radiotherapy in excised brain metastases.Radiation oncology journal · 2025
- Using the genomic adjusted radiation dose (GARD) to personalize the radiation dose in nasopharyngeal cancer.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2024
- Efficacy, safety, and correlative biomarkers of bintrafusp alfa in recurrent or metastatic nasopharyngeal cancer patients: a phase II clinical trial.The Lancet regional health. Western Pacific · 2023
- Explainable machine learning via intra-tumoral radiomics feature mapping for patient stratification in adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma.La Radiologia medica · 2023
- Effects of Patient-Reported Outcome Tracking and Health Information Provision via Remote Patient Monitoring Software on Patient Outcomes in Oncology Care: A Systematic Review and Meta-Analysis.Seminars in oncology nursing · 2023
- Combining Transoral Nasopharyngeal Brush and Plasma Epstein-Barr Virus DNA in Detecting Locally Recurrent Nasopharyngeal Carcinoma.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2023
- Management of Nasopharyngeal Carcinoma in Elderly Patients.Frontiers in oncology · 2022
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
For reference only. Not medical advice. Read full disclaimer